Nicole Davarpanah, Chief Medical Officer of Cidara Therapeutics ($CDTX), made one open market sale of company shares in the last year, totaling nearly $30,000. Her most recent sale occurred on September 11, 2025. This places her 10,831st among 11,678 insiders ranked by sale value in our database, where the average is $8.6 million across about 6.4 transactions per insider. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Employee Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.06% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Common Stock | 8333 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.03% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.03% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Employee Stock Option (right to buy) | 5000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.02% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Employee Stock Option (right to buy) | 62597 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.20% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Employee Stock Option (right to buy) | 30000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.10% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | D | Common Stock | 12553 | $221.50 | 8,333.0000 | 31,439,371 | 60.10% | 0.04% |
| Dec. 29, 2025 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | G | Common Stock | 450 | $0.00 | 20,886.0000 | 31,439,371 | 2.11% | 0.00% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | F | Common Stock | 10332 | $219.60 | 21,286.0000 | 31,439,371 | 32.68% | 0.03% |
| Sept. 11, 2025 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | S | Common Stock | 474 | $62.86 | 31,418.0000 | 10,953,490 | 1.49% | 0.00% |
| May 1, 2025 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | A | Employee Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 10,953,490 | 9999.99% | 0.18% |
| May 1, 2025 | Cidara Therapeutics, Inc. | $CDTX | Davarpanah Nicole Negar | Chief Medical Officer | A | Common Stock | 10000 | $0.00 | 31,692.0000 | 10,953,490 | 46.10% | 0.09% |